IRIS
LASCO, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.284
EU - Europa 9.022
AS - Asia 4.522
SA - Sud America 1.430
Continente sconosciuto - Info sul continente non disponibili 331
AF - Africa 121
OC - Oceania 10
Totale 24.720
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.021
RU - Federazione Russa 4.662
SG - Singapore 1.846
CN - Cina 1.457
BR - Brasile 1.184
IE - Irlanda 1.083
SE - Svezia 951
DE - Germania 570
IT - Italia 568
HK - Hong Kong 442
FR - Francia 329
VN - Vietnam 247
FI - Finlandia 246
GB - Regno Unito 180
UA - Ucraina 138
IN - India 136
CA - Canada 109
PL - Polonia 107
AR - Argentina 85
BD - Bangladesh 60
TR - Turchia 53
EC - Ecuador 46
IQ - Iraq 41
MX - Messico 39
NL - Olanda 36
BE - Belgio 34
VE - Venezuela 31
PK - Pakistan 28
JP - Giappone 25
ES - Italia 23
ZA - Sudafrica 23
CO - Colombia 22
ID - Indonesia 22
MA - Marocco 22
CL - Cile 20
UZ - Uzbekistan 20
PY - Paraguay 17
HN - Honduras 16
EG - Egitto 15
GT - Guatemala 15
AT - Austria 14
CZ - Repubblica Ceca 14
JO - Giordania 14
NI - Nicaragua 14
PH - Filippine 14
SA - Arabia Saudita 13
IL - Israele 12
JM - Giamaica 12
TT - Trinidad e Tobago 12
UY - Uruguay 12
CI - Costa d'Avorio 10
CR - Costa Rica 10
AZ - Azerbaigian 9
CH - Svizzera 9
DZ - Algeria 9
LT - Lituania 9
SC - Seychelles 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
KE - Kenya 8
NP - Nepal 8
KR - Corea 7
KZ - Kazakistan 7
MY - Malesia 7
PE - Perù 7
SN - Senegal 7
SV - El Salvador 7
AL - Albania 6
BG - Bulgaria 6
BH - Bahrain 6
CU - Cuba 6
DO - Repubblica Dominicana 6
GP - Guadalupe 6
IR - Iran 6
KG - Kirghizistan 6
TN - Tunisia 5
BO - Bolivia 4
DK - Danimarca 4
EE - Estonia 4
ET - Etiopia 4
HU - Ungheria 4
RO - Romania 4
BN - Brunei Darussalam 3
GE - Georgia 3
GR - Grecia 3
LV - Lettonia 3
NG - Nigeria 3
NO - Norvegia 3
PR - Porto Rico 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
OM - Oman 2
PA - Panama 2
Totale 24.360
Salva come PNG Salva come JPEG
Città #
Ashburn 1.368
Moscow 1.256
Dublin 1.080
Singapore 1.028
Chandler 781
Dallas 711
San Jose 571
Nyköping 514
Beijing 505
Hong Kong 416
Jacksonville 377
Munich 257
The Dalles 241
Council Bluffs 236
Princeton 194
Dearborn 190
Los Angeles 179
New York 167
Medford 153
Lauterbourg 148
Messina 148
Ann Arbor 145
Cambridge 133
Bremen 124
Des Moines 118
Boardman 104
Warsaw 93
São Paulo 91
Ho Chi Minh City 85
Helsinki 79
Santa Clara 75
Guangzhou 72
Jinan 67
Buffalo 65
Tianjin 63
Shenyang 57
Hanoi 55
Turku 54
Nanjing 50
San Mateo 48
Atlanta 47
Frankfurt am Main 46
Wilmington 46
Catania 45
Houston 45
Pune 43
Redondo Beach 43
Orem 42
Seattle 39
Lancaster 36
Woodbridge 36
Montreal 34
Rio de Janeiro 34
Brussels 33
North Bergen 32
Belo Horizonte 30
Brooklyn 29
Curitiba 29
Hebei 28
Zhengzhou 27
Haikou 26
Brasília 25
Hangzhou 25
Boston 24
Chennai 24
Milan 24
Nanchang 24
Düsseldorf 23
Phoenix 22
Denver 21
London 21
Nuremberg 21
San Francisco 21
Taizhou 21
Baghdad 20
Chicago 20
Rome 19
Hyderabad 18
Porto Alegre 18
Quito 18
Strasbourg 18
Tashkent 18
Tokyo 18
Johannesburg 17
Newark 17
Toronto 17
Ningbo 16
Amsterdam 15
Fuzhou 15
Poplar 15
Jiaxing 14
Goiânia 13
Managua 13
Manchester 13
Shanghai 13
Taiyuan 13
Guatemala City 12
Lahore 12
Manaus 12
Stockholm 12
Totale 13.570
Salva come PNG Salva come JPEG
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 318
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 302
Anxiety levels as risk factor for osteoporosis in postmenopausal women 284
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 276
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 274
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 263
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 253
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 247
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 243
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 242
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 239
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 236
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 235
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 232
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 232
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 217
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 213
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 212
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 210
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 204
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 203
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 200
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 198
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 197
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 196
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 194
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 194
Hyponatremia as a leading sign of hypopituitarism 190
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 188
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 187
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 184
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 184
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 182
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 182
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 180
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 179
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 178
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 178
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 176
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 175
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 175
Frailty and lipid profile in elderly hospitalized patients 174
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 174
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 174
IL-22 circulating serum levels in centenarians. 173
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 173
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 173
Healthy centenarians show high levels of circulating interleukin-22 (IL-22). 170
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 170
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 170
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 169
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 168
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 168
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 167
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 163
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 163
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 163
Frailty modifications and prognostic impact in older patients admitted in acute care 163
Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery 162
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 162
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 162
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 159
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 159
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 159
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 159
Electrocardiographic changes in centenarians: a study on 42 subjects and comparison with the literature 158
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 158
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 158
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 158
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 158
Valutazione e comparazione del filtrato glomerulare stimato con due differenti formule in una popolazione di centenari 157
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 157
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 156
Sincope conseguente a severa depressione della conduzione atrio-ventricolare trattata con impianto di Pace-maker in un soggetto anziano affetto da fibrillazione atriale permanente e demenza in trattamento con rivastigmina 156
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 156
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 156
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 155
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 155
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 154
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 154
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 153
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 153
Relationship between blood pressure and frailty in older hypertensive outpatients 153
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 151
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 151
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 149
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 148
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 147
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 147
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 147
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 145
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 145
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 145
L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia 145
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 145
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 144
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 143
Effect of long-term treatment with raloxifene on mammary density in postmenopausal women 142
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 140
DISAPPEARANCE OF A VIRILIZING ADRENAL TUMOR FOLLOWING THERAPY WITH CYPROTERONE ACETATE. 140
Totale 18.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.035 0 0 0 0 33 9 106 39 122 210 127 389
2022/20233.155 225 332 153 206 307 286 21 175 1.314 15 88 33
2023/2024811 62 135 34 107 57 189 19 58 6 27 12 105
2024/20253.519 55 58 61 213 180 111 115 675 898 230 328 595
2025/202610.719 588 845 618 693 899 2.219 1.275 1.471 1.397 416 143 155
2026/20272.362 319 864 477 601 101 0 0 0 0 0 0 0
Totale 24.720